Navigation Links
HemaQuest Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease
Date:4/25/2011

nd biologic effects on fetal hemoglobin induction and red blood cell production in the laboratory, relevant animal models, and in clinical trials carried out in healthy human subjects as well as patients with sickle cell disease and beta thalassemia. The compound has received Orphan Drug Designation in the United States and Europe for both sickle cell disease and beta thalassemia.

ABOUT SICKLE CELL DISEASE Sickle cell disease is a genetic blood disorder that affects approximately 110,000 patients in the U.S. and Europe and 250,000 in the Middle East. Sickle cell disease is characterized by production of an abnormal beta hemoglobin chain of adult hemoglobin, which results in distorted, rigid sickle red blood cells, which block blood vessels, causing lack of oxygen to tissues, acute episodes of pain (pain crises), lung injury (acute chest syndrome), and strokes. Infections are common, and chronic damage occurs in many organs, including the spleen, bones, kidneys, lungs, brain, and eyes. The sole drug which is approved to treat the disease is a cancer chemotherapy drug, hydroxyurea.  The lifespan of sickle cell patients is markedly reduced.

ABOUT HEMAQUEST PHARMACEUTICALS, INC.HemaQuest Pharmaceuticals (www.HemaQuest.com), established in late 2007, is a San Diego and Seattle-based biopharmaceutical company focused on developing small molecule therapeutics based on its proprietary SCFAD technologies to treat hemoglobin diseases. HemaQuest is also developing a proprietary multi-drug therapeutic approach for treating viral-associated malignancies, with a primary focus on Epstein-Barr virus associated lymphomas. The Company's investors include De Novo Ventures, Forward Ventures, Lilly Ventures, Aberdare Ventures and Latterell Venture Partners.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective f
'/>"/>

SOURCE HemaQuest Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing
2. HemaQuest Announces Appointment of New Executive Management Team; Company Establishes Headquarters in San Diego
3. HemaQuest Pharmaceuticals, Inc. Presents Promising Clinical Results at 52nd Annual Meeting of the American Society of Hematology (ASH)
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , 22 de mayo de 2015 /PRNewswire/ ... ), una compañía farmacéutica de fase tardía ... Locilex® (pexiganan cream 0.8%), y colaboradores de ... de póster destacando el diseño innovador de ... la Compañía que evalúan Locilex®, su nuevo ...
(Date:5/22/2015)... , May 22, 2015 Electrophysiologist Kevin ... recently traveled to Boston, MA ... the 2015 Heart Rhythm Society conference. These scientific ... focus on the ideas, people and technology that ... is a hybrid, minimally invasive cardiac operation that ...
(Date:5/22/2015)... and KING OF PRUSSIA, Pa. ... (NHF) has awarded CSL Behring its 2015 ... unwavering commitment to advancing science and improving the care of ... Paul Perreault , CEO and Managing Director, CSL Limited, during ... City on May 21. "The National ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4
... Ltd today announced that it will be exhibiting at EHS ... Mark approval this year for TIGR® Matrix ... To mark the occasion, a special presentation has ... venue in Ghent  ( http://www.novusscientific.com/events/ ), featuring renowned surgeons; ...
... 2011 Program officials have confirmed that they will ... assistance program called Illinois Rx Card at a news ... Illinois Rx Card is being launched to help the ... program is being touted as the answer for Illinois ...
Cached Medicine Technology:TIGR® Matrix Surgical Mesh - Exhibited Ahead of Anticipated CE Mark Approval at European Hernia Society 2011, Ghent, Belgium 2
(Date:5/22/2015)... Pa (PRWEB) May 22, 2015 ... (AHN) today announced a new partnership to develop ... for the region. The initiative includes a new exhibit ... live demonstration theater, and a new traveling science ... the fall of 2015. , Designed to explore ...
(Date:5/22/2015)... According to a new Aegis Living Study on Attitudes Toward ... worry about what will happen to their memory as they ... Generation), which may help explain why nearly half of all ... (47%), Gen X’ers (51%), and Boomers (43%). The study was ... than 2,000 U.S. adults ages 18+. , “This study ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 ... Health IT solutions, announced today that Bill Lane, ... is the developer of BlueEHS,a first of its ... offers a customizable Electronic Health Records (EHR) with ... interfaces, a telemedicine-enabled comprehensive patient portal, and more. ...
(Date:5/22/2015)... 2015 Gateway Building Concepts is experienced ... services the company specialize in include decks, additions, kitchen ... houses and much more. , The redesigned logo ... of the company. It includes two geometrical lines that ... thought out to be used with many things associated ...
(Date:5/22/2015)... Alexandria, VA (PRWEB) May 22, 2015 ... be presented at the American Society of Clinical ... May, demonstrated improved survival rates for those patients ... standard chemotherapy regimen of pemetrexed/cisplatin. Bevacizumab (Avastin® Genentech, ... vessel growth), and it is already routinely used ...
Breaking Medicine News(10 mins):Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2
... on a transporter that actually quietens the body’s natural ... potent and non-habit //forming pain killers and will help ... ,Opioid peptides are natural pain relievers with receptors – ... the body, says Dr. Vadivel Ganapathy, chair of the ...
... on animal health has declared India as free from the ... intestinal tract of cattle //. ,'This recognition of ... It is the first animal disease to be officially recognised ... from India,' agriculture ministry said in a statement Friday. ...
... changing lifestyles has led to Himachal Pradesh having one of ... to a survey //. ,The latest countrywide findings of ... Pradesh out of every 100,000 people, 195 had a mental ... carried out after 11 years. ,Kerala has the ...
... Medical School it is said that a resistant bacteria was ... patients. // Pseudomonas aeruginosa (PA) is the bacteria which secretes ... Mougous, lead author of the study published in the June ... the host may be a cancer patient with a weakened ...
... doctors’ role in interrogating detainees, but ... a role, claiming that it can lead interrogaters’ to ... of medical advice. ,Medical professionals were used by ... lot of flak from human rights groups and medical ...
... popular excuse "not tonight, I have a headache," a ... activity and says that sexual desire and migraine may ... ,In fact, migraine sufferers reported higher levels of ... according to researchers from Wake Forest University School of ...
Cached Medicine News:Health News:Transporter offers reliable clues for safer pain medicine 2Health News:Transporter offers reliable clues for safer pain medicine 3Health News:India Declared Free of Rinderpest Cattle Infection 2Health News:Treatment of Bacterial Infection Paves the Way to Treat CF Infection 2Health News:Medical Role In Interrogations Curtailed By Pentagon 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: